X
19
Melinta Therapeutics, based in U.S.A, is a pharmaceutical company.
One of their notable products is DELAFLOXACIN MEGLUMINE, with a corresponding application number 208611 and regulatory information .
proudly manufactured in the
approval since 2017-06-19
Melinta Therapeutics's BAXDELA POWDER;INTRAVENOUS, medication with EQ 300MG BASE/VIAL of DELAFLOXACIN MEGLUMINE.